JP2017222671A5 - - Google Patents

Download PDF

Info

Publication number
JP2017222671A5
JP2017222671A5 JP2017130471A JP2017130471A JP2017222671A5 JP 2017222671 A5 JP2017222671 A5 JP 2017222671A5 JP 2017130471 A JP2017130471 A JP 2017130471A JP 2017130471 A JP2017130471 A JP 2017130471A JP 2017222671 A5 JP2017222671 A5 JP 2017222671A5
Authority
JP
Japan
Prior art keywords
compound
conjugate
protein
immunogenic carrier
ovalbumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017130471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017222671A (ja
JP6423490B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017222671A publication Critical patent/JP2017222671A/ja
Publication of JP2017222671A5 publication Critical patent/JP2017222671A5/ja
Application granted granted Critical
Publication of JP6423490B2 publication Critical patent/JP6423490B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017130471A 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン Active JP6423490B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261691454P 2012-08-21 2012-08-21
US61/691,454 2012-08-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015528568A Division JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018196525A Division JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Publications (3)

Publication Number Publication Date
JP2017222671A JP2017222671A (ja) 2017-12-21
JP2017222671A5 true JP2017222671A5 (OSRAM) 2018-02-22
JP6423490B2 JP6423490B2 (ja) 2018-11-14

Family

ID=49081007

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン
JP2017130471A Active JP6423490B2 (ja) 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Country Status (11)

Country Link
US (1) US9303041B2 (OSRAM)
EP (2) EP2888269B1 (OSRAM)
JP (3) JP6171014B2 (OSRAM)
CN (1) CN104854110B (OSRAM)
AU (1) AU2013306018B2 (OSRAM)
CA (1) CA2882454C (OSRAM)
ES (2) ES2701062T3 (OSRAM)
PL (1) PL2888269T3 (OSRAM)
PT (1) PT2888269T (OSRAM)
TR (1) TR201816378T4 (OSRAM)
WO (1) WO2014031587A1 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9494608B2 (en) 2012-08-21 2016-11-15 Janssen Pharmaceutica Nv Antibodies to olanzapine and use thereof
PT2888592T (pt) 2012-08-21 2018-01-29 Janssen Pharmaceutica Nv Anticorpos contra a quetiapina e sua utilização
PT3462173T (pt) 2012-08-21 2021-04-28 Janssen Pharmaceutica Nv Anticorpos contra risperidona e utilização dos mesmos
PT2888234T (pt) 2012-08-21 2018-02-22 Janssen Pharmaceutica Nv Haptenos de aripiprazol e seu uso em imunoensaios
JP6374387B2 (ja) 2012-08-21 2018-08-15 ヤンセン ファーマシューティカ エヌ.ベー. リスペリドンハプテンへの抗体及びその使用
CN110054694B (zh) 2012-08-21 2024-02-20 詹森药业有限公司 阿立哌唑半抗原的抗体及其用途
CN104755093B (zh) 2012-08-21 2018-11-16 詹森药业有限公司 奥氮平半抗原的抗体及其用途
CN110054693A (zh) 2012-08-21 2019-07-26 詹森药业有限公司 喹硫平半抗原的抗体及其用途
EP2888269B1 (en) * 2012-08-21 2018-10-24 Janssen Pharmaceutica NV Haptens of olanzapine
HK1211958A1 (en) 2012-08-21 2016-06-03 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone and use thereof
HK1211956A1 (en) 2012-08-21 2016-06-03 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone haptens and use thereof
AU2013305879B2 (en) 2012-08-21 2017-10-12 Saladax Biomedical Inc. Antibodies to aripiprazole and use thereof
US10435478B2 (en) 2015-12-17 2019-10-08 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
US10444250B2 (en) 2015-12-17 2019-10-15 Janssen Pharmaceutica Nv Antibodies to risperidone and use thereof
CN110938082A (zh) * 2019-10-30 2020-03-31 杭州博拓生物科技股份有限公司 一种奥氮平人工抗原及其制备方法
CN110950808A (zh) * 2019-10-30 2020-04-03 杭州博拓生物科技股份有限公司 一种氯氮平人工抗原及其制备方法
WO2022136343A1 (en) * 2020-12-22 2022-06-30 Intervet International B.V. Conjugated zearalenone to protect against mycotoxicosis
CN114685477B (zh) * 2020-12-25 2023-11-17 长沙博源医疗科技有限公司 一种利奈唑胺衍生物、免疫原、抗利奈唑胺特异性抗体及其制备方法与应用
CN114685527B (zh) * 2020-12-25 2024-03-05 长沙博源医疗科技有限公司 一种奥氮平衍生物、免疫原、抗奥氮平特异性抗体及其制备方法与应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
DK0582368T3 (da) * 1992-05-29 2001-02-05 Lilly Co Eli Thienobenzodiazepinderivater til behandling af forstyrrelser i centralnervesystemet
ATE176329T1 (de) * 1992-06-26 1999-02-15 Johnson & Johnson Clin Diag Immunotests unter verwendung von markierten thyronin-analogen
US5395933A (en) * 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
UA76708C2 (uk) * 1999-12-08 2006-09-15 Сінгента Патисипейшонс Аг Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
JP2005533009A (ja) * 2002-03-28 2005-11-04 イーライ・リリー・アンド・カンパニー ピペラジン置換されたアリールベンゾジアゼピン類およびそのドーパミン受容体アンタゴニストとしての精神病性障害の処置のための使用
DE60313634T2 (de) 2002-08-05 2008-01-31 Eli Lilly And Co., Indianapolis Piperazinsubstituierte arylbenzodiazepine
JP2007505864A (ja) 2003-09-23 2007-03-15 フェルミオン オサケ ユキチュア クエチアピンの製造
AU2005281359A1 (en) * 2004-08-26 2006-03-16 Apparao Satyam Prodrugs and codrugs containing novel bio-cleavable disulfide linkers
TW200616604A (en) * 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
KR20100075455A (ko) 2007-09-27 2010-07-02 노파르티스 아게 약물 모니터링 분석법
WO2010033270A1 (en) 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
JP5749169B2 (ja) 2008-10-14 2015-07-15 アストラゼネカ アクチボラグ 細菌感染の処置用の縮合スピロ環式ヘテロ芳香族化合物
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
CA2889457C (en) 2009-12-31 2016-06-28 Kempharm, Inc. Amino acid conjugates of quetiapine, process for making and using the same
US8900604B2 (en) 2010-03-11 2014-12-02 Kempharm, Inc. Fatty acid conjugates of quetiapine, process for making and using the same
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
JP5952912B2 (ja) * 2011-12-15 2016-07-13 アルカーメス ファーマ アイルランド リミテッド 二級アミン化合物のプロドラッグ
EP2888269B1 (en) * 2012-08-21 2018-10-24 Janssen Pharmaceutica NV Haptens of olanzapine

Similar Documents

Publication Publication Date Title
JP2017222671A5 (OSRAM)
JP2015532645A5 (OSRAM)
JP2015527363A5 (OSRAM)
JP2018184433A5 (OSRAM)
JP2015181191A5 (OSRAM)
RU2013133802A (ru) Стабильные и растворимые антитела, ингибирующие vegf
JP2010043124A5 (OSRAM)
JP2019524645A5 (OSRAM)
JP2016535744A5 (OSRAM)
JP2009120624A5 (OSRAM)
CN109843873A (zh) 炔代杂环化合物、其制备方法及其在医药学上的应用
WO2018102315A8 (en) Polymorphs of sepiapterin and salts thereof
JP2013539454A5 (OSRAM)
JP2012001634A5 (OSRAM)
RU2019110152A (ru) Лекарственные средства на основе лантионинсинтетаза c-подобного белка 2
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
CN110612292A (zh) 奥扎莫德加成盐晶型、制备方法及药物组合物和用途
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
WO2019027173A3 (ko) 신규한 싸이코스-6-인산 탈인산효소, 상기 효소를 포함하는 사이코스 생산용 조성물, 상기 효소를 이용하여 사이코스를 제조하는 방법
CN112262136A (zh) 一种吡咯并氨基哒嗪酮化合物的制备方法及其中间体
CO2017000010A2 (es) Proceso para la preparacion de ácidos 3-hidroxipicolínicos
JP2012515709A5 (OSRAM)
RU2016107486A (ru) Способ получения рифаксимина к
JP2013503145A5 (OSRAM)
MX393759B (es) Suspensiones inyectables